Blog

November 4, 2020

Mission Bio launches single-cell multi-omics system for precision cancer therapies

Read the full article, here.

Mission Bio has launched the Tapestri Single-cell Multi-omics Solution – a comprehensive single-cell multi-omics platform. With a new instrument, single-cell multi-omics reagent kits, TotalSeq-D antibody content from BioLegend, and visualisation software, the package provides layered insight into multiple analytes across all blood cancers, reducing drug development time and cost by at least half. The company has parterned with BioLegend, provider of antibodies and reagents, to develop antibody panels for single-cell protein detection with the new device.

© 2020 Mighty Capital All Rights Reserved